Status:
COMPLETED
Computer-based Intervention for Alcohol-using HIV/HCV+ Women
Lead Sponsor:
New York University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Human Immunodeficiency Virus
Hepatitis C
Eligibility:
FEMALE
21-45 years
Phase:
NA
Brief Summary
The study harnessed the multidisciplinary expertise of our research team to develop a brief, computer-based, alcohol reduction intervention tailored for HIV/HCV co-infected women and evaluate its effi...
Detailed Description
Women co-infected with human immunodeficiency viruses (HIV) and Hepatitis C (HCV) are at elevated risk for adverse health outcomes associated with alcohol use. Evidence-based alcohol reduction interve...
Eligibility Criteria
Inclusion
- female;
- receiving HIV medical care at the AIDS Center;
- chart-documented HIV and chronic HCV infection;
- currently prescribed an antiretroviral (ARV) regimen;
- medically, cognitively, and psychologically capable of study participation;
- laboratory-confirmed recent alcohol use as detected by a Ethylglucuronide (EtG) analysis or self-reported alcohol use
Exclusion
- not identifying as biological female
- not HIV and HCV positive
- no laboratory-confirmed or self-reported
- not willing to participate in the trial
- not able to participate in the trial due to medical, cognitive, or psychological issues
Key Trial Info
Start Date :
January 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03362476
Start Date
January 3 2018
End Date
February 28 2022
Last Update
January 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University
New York, New York, United States, 10003
2
North West District AIDS Center
Saint Petersburg, Russia, 197376